Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Initiative Disclosure topic
No spam. Unsubscribe anytime.
Senate amends initiative‑disclosure bill, exempts fluoride measure from 15% threshold
Summary
The Senate advanced House Bill 142 requiring fiscal disclosure on initiative petitions but accepted an amendment exempting fluoride questions from a 15% fiscal overrun rule (the threshold was later raised to 25%). Lawmakers debated whether singling out fluoride undermined the bill's intent.
Senator Bramble explained House Bill 142, which would require fiscal impact disclosure on initiative signature pages, ballots and information pamphlets following concerns about previous initiative petitions. The measure aimed to give voters clearer information about potential costs associated with initiatives.
A major floor fight focused on an amendment that exempted fluoridation initiatives from the bill's 15% fiscal‑overrun threshold. Senator Thomas and others argued that exempting fluoride would undercut the bill's intent to prevent ‘‘bait and switch’’ initiatives by ensuring petition signers and voters see reasonably accurate cost estimates. Senator Eastman and proponents countered that the fluoride initiative process is governed by separate statutory language and that local variances in fluoridation equipment and delivery make the 15% threshold arbitrary for fluoridation measures.
Senators debated whether the amendment ‘‘guts’’ the disclosure requirement for fluoride; Bramble said the combined bill addressed two related but distinct policy problems and that excluding fluoride from the 15% rule did not eliminate the broader disclosure requirements. The Senate then adopted a friendly amendment increasing the overrun threshold from 15% to 25% in multiple locations in the bill and passed the amended bill on a roll call (19 yes, 6 no, 4 absent) and sent it back to the House for further action.
What happens next: HB142 will proceed to the House with the Senate's amendments. The debate illustrates tensions between transparency aims and special‑case policy adjustments tied to the unique statutory treatment of fluoridation initiatives; advocates for broader disclosure say the change could be revisited in future sessions.
